soul trial oral semaglutide cardiovascular outcomes 2024 results mace 🔴Cardiovascular with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants SOUL: Oral Semaglutide Cuts CV
Description
Your Microbiome Your gut bacteria ferment dietary fiber and produce short-chain fatty acids (SCFAs) like butyrate and propionate
This matters
if confirmed, semaglutide should not be restarted
In this review, the impact of various edible forms of oats like whole, naked, sprouted, or supplemented has been investigated for their appetite hormones regulation and weight management
Assessment of whole body physiology in metabolic cages revealed LdistalDq cell stimulation increased energy expenditure and increased activity
Discover how Whole-Body EMS can help preserve muscle during weight loss with GLP-1s, ensuring long-term success and metabolic health.
